Atlas Trials

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Clinical trial NCT04264078 · UNKNOWN

Trial details

NCT number
NCT04264078
Sponsor
Xinqiao Hospital of Chongqing
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
T-cell LeukemiaT-cell Lymphoma
Start date
2021-03-01
Primary completion
2022-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.